Tomatoes, lycopene and prostate cancer: a clinician's guide for counseling those at risk for prostate cancer

Kamal S Pohar1, Michael C Gong, Robert Bahnson

  • 1Division of Urology, Department of Surgery, Ohio State University College of Medicine and Public Health, 4841 UHC, 456 West 10th Avenue, Columbus, OH 43210, USA. pohar-1@medctr.osu.edu

Insights

Lycopene, found in tomatoes, may lower prostate cancer risk. Further research into its absorption, antioxidant role, and metabolism is crucial for understanding its chemopreventive potential.

Area of Science:

  • Oncology
  • Nutritional Science
  • Epidemiology

Background:

  • Prostate cancer is a significant public health concern.
  • Research is actively seeking risk factors and chemopreventive agents.
  • Epidemiological studies suggest a link between tomato product consumption and reduced prostate cancer risk.

Purpose of the Study:

  • To investigate lycopene as a potential chemopreventive agent for prostate cancer.
  • To assess the efficacy of pure lycopene in cancer prevention.
  • To deepen the understanding of lycopene's biological mechanisms.

Main Methods:

  • Review of laboratory and clinical studies on lycopene.
  • Analysis of epidemiological data associating tomato consumption with prostate cancer risk.
  • Focus on lycopene's absorption, distribution, antioxidant properties, and metabolism.

Main Results:

  • Lycopene, a carotenoid abundant in tomatoes, is hypothesized to be responsible for the observed reduction in prostate cancer risk.
  • Preliminary studies suggest lycopene's potential as a chemopreventive agent.
  • Further investigation is needed to confirm these findings.

Conclusions:

  • Lycopene is a promising candidate for prostate cancer chemoprevention.
  • Understanding lycopene's mechanisms of action, including its antioxidant role and metabolism, is critical.
  • Continued research is essential to elucidate how lycopene may reduce prostate cancer risk.

Related Concept Videos

Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Urinary Tract Calculi IV: Nutrition Therapy and Prevention01:27

Urinary Tract Calculi IV: Nutrition Therapy and Prevention

Management of renal calculi focuses on effective strategies like tailored nutrition and hydration therapy. Adjusting diet and fluid intake reduces stone formation and recurrence, making these interventions simple yet powerful in kidney stone prevention and management.Understanding Kidney StonesKidney stones form when calcium, oxalate, uric acid, and cystine concentrate and crystallize in urine. Factors contributing to their formation include genetic predisposition, certain medical conditions,...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...